XML 27 R15.htm IDEA: XBRL DOCUMENT

CONCENTRATION OF RISK	9 Months Ended
CONCENTRATION OF RISK	Sep. 30, 2017
Risks and Uncertainties [Abstract]
Concentration of Risk	CONCENTRATION OF RISK Customer and Credit Concentration Risk The Company provides trade credit to its customers in the normal course of business. One commercial payor, United Healthcare, accounted for approximately 18.1% and 24.1% of revenue during the three months ended September 30, 2017 and 2016, respectively, and approximately 21.0% and 24.8% of revenue during the nine months ended September 30, 2017 and 2016, respectively. This contract, exclusive of certain provisions, terminated effective September 30, 2017. In addition, Medicare accounted for approximately 9.9% and 7.6% of revenue during the three months ended September 30, 2017 and 2016, respectively, and 7.9% and 7.7% of revenue during the nine months ended September 30, 2017 and 2016. Therapy Revenue Concentration Risk The Company sells products related to the Immune Globulin therapy, which represented 21.3% and 19.1% of revenue for the three months ended September 30, 2017 and 2016, respectively, and 21.5% and 17.8% of revenue for the nine months ended September 30, 2017 and 2016.